Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Am J Physiol Regul Integr Comp Physiol ; 293(1): R372-8, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17459910

ABSTRACT

Obstructive sleep apnea involves intermittent periods of airway occlusions that lead to repetitive oxygen desaturations. Exposure to chronic intermittent hypoxia (IH) in rats increases diurnal blood pressure and alters skeletal muscle physiology. The impact of IH on upper airway muscle function is unknown. We hypothesize that IH exposure increases upper airway collapsibility in rats due to alterations of the muscles surrounding the upper airway. Lean and obese rats were exposed to cyclic alterations in O(2) levels (20.6%-5%) every 90 s, 8 h/day for 6 days/wk for 12 wk. Following the exposure period, arterial pressure was recorded via the tail artery in conscious unrestrained rats. Mean arterial pressure was increased in lean IH but not in obese IH-exposed Zucker rats (P < 0.05). The pharyngeal pressure associated with airway collapse (P(crit)) was measured under anesthesia during baseline conditions and then during supramaximal stimulation of the hypoglossal nerve (cnXII). Baseline P(crit) was more positive (more collapsible) in lean but not obese rats following 12 wk of IH (P < 0.05), while supramaximal stimulation of cnXII increased airway stability (decreased P(crit)) in both lean and obese Zucker rats following IH to levels that were similar to their respective room air controls. The in vitro peak tension and the expression of the individual myosin heavy chain isoforms from the upper airway muscles were unaltered following IH. We conclude that IH leads to increases in baseline collapsibility in lean Zucker rats exposed to IH by nonmyogenic mechanisms.


Subject(s)
Hypoxia/physiopathology , Obesity/physiopathology , Respiratory System/physiopathology , Animals , Blood Pressure/physiology , Body Weight/physiology , Electrophoresis, Polyacrylamide Gel , Male , Muscle Contraction/physiology , Muscle Fatigue/physiology , Myosin Heavy Chains/analysis , Myosin Heavy Chains/metabolism , Rats , Rats, Zucker , Respiratory Mechanics/physiology , Respiratory Muscles/physiopathology
2.
Am J Respir Crit Care Med ; 170(7): 804-10, 2004 Oct 01.
Article in English | MEDLINE | ID: mdl-15256396

ABSTRACT

The effects of [+/-]-2,5-dimethoxy-4-iodoaminophentamine, a serotonin(2A/2C) receptor agonist, on pharyngeal airflow mechanics were examined in isoflurane-anesthetized lean and obese Zucker rats. The pharyngeal pressure associated with flow limitation, maximum inspiratory flow, oronasal resistance, genioglossus muscle activity, and arterial blood pressure (BP) were measured before and after the intravenous administration of the agonist. A robust activation of the genioglossus muscle in all lean and obese rats was associated with decreased upper airway (UA) collapsibility (p < 0.05), unchanged maximum flow, and increased oronasal resistance (p < 0.05) in both groups. The changes in UA mechanics and BP after the drug were similar in lean and obese rats. The serotonin agonist had no effect on UA mechanics in a group of paralyzed (pancuronium bromide) rats, despite similar elevations in BP. There was a smaller decrease (p < 0.05) in UA collapsibility that was also associated with increased upstream resistance when the drug was administered after bilateral hypoglossal nerve transection. We conclude that systemic administration of a serotonin(2A/2C) receptor agonist improves UA collapsibility predominantly, but not exclusively, via stimulation of the hypoglossal nerves and also increases upstream resistance, at least in part, through activation of nonhypoglossal motoneuronal pools innervating the UA muscles.


Subject(s)
Amphetamines/therapeutic use , Disease Models, Animal , Obesity/complications , Serotonin Receptor Agonists/therapeutic use , Sleep Apnea, Obstructive/drug therapy , Airway Resistance/drug effects , Amphetamines/pharmacology , Analysis of Variance , Animals , Blood Pressure/drug effects , Denervation , Diastole , Drug Evaluation, Preclinical , Hypoglossal Nerve/physiology , Motor Neurons/drug effects , Pharyngeal Muscles/drug effects , Pharyngeal Muscles/innervation , Pharyngeal Muscles/physiopathology , Rats , Rats, Zucker , Receptor, Serotonin, 5-HT2A/physiology , Receptor, Serotonin, 5-HT2C/physiology , Respiratory Mechanics/drug effects , Serotonin 5-HT2 Receptor Agonists , Serotonin Receptor Agonists/pharmacology , Sleep Apnea, Obstructive/etiology , Sleep Apnea, Obstructive/physiopathology , Systole , Thinness/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...